French Health Tech Giant Eyes Major Secondary Investment

December 16, 2025 - 19:46

Doctolib, once France’s most valuable startup, was worth $6.4 billion at its previous funding round in 2022. The company is now planning a significant secondary investment that could amount to hundreds of millions. This move is expected to bolster its financial standing and facilitate further growth in the competitive health tech sector.

Founded in 2013, Doctolib has revolutionized the way patients book medical appointments and manage their healthcare. With a user-friendly platform that connects patients and healthcare professionals, the startup has gained immense popularity across France and Germany. The impending investment is anticipated to enhance its technological capabilities and expand its market reach.

As the demand for digital health solutions continues to rise, Doctolib's strategic financial maneuvering positions it well to capitalize on emerging opportunities. This secondary investment not only reflects investor confidence but also underscores the importance of innovation in the healthcare landscape.